Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma brucei | cAMP-dependent protein kinase catalytic subunit 2 | 0.0212 | 0.4985 | 1 |
Echinococcus multilocularis | cyclins | 0.0185 | 0.3185 | 0.6388 |
Brugia malayi | Cyclin, N-terminal domain containing protein | 0.0185 | 0.3185 | 0.3185 |
Echinococcus multilocularis | enhancer of mRNA decapping protein 4 | 0.0207 | 0.4643 | 0.9314 |
Brugia malayi | Cyclin, N-terminal domain containing protein | 0.0185 | 0.3185 | 0.3185 |
Plasmodium falciparum | cyclin | 0.0185 | 0.3185 | 0.6388 |
Echinococcus multilocularis | cAMP dependent protein kinase catalytic subunit | 0.0212 | 0.4985 | 1 |
Trichomonas vaginalis | cyclins, putative | 0.0185 | 0.3185 | 0.6388 |
Trichomonas vaginalis | cyclin B, putative | 0.0185 | 0.3185 | 0.6388 |
Toxoplasma gondii | protein kinase, cAMP-dependent, catalytic chain | 0.0212 | 0.4985 | 1 |
Plasmodium falciparum | cAMP-dependent protein kinase catalytic subunit | 0.0212 | 0.4985 | 1 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0212 | 0.4985 | 1 |
Loa Loa (eye worm) | cyclin domain-containing protein | 0.0185 | 0.3185 | 0.3185 |
Schistosoma mansoni | cyclin B3 | 0.0185 | 0.3185 | 0.6388 |
Echinococcus granulosus | G2:mitotic specific cyclin B3 | 0.0185 | 0.3185 | 0.6388 |
Trichomonas vaginalis | AGC family protein kinase | 0.0212 | 0.4985 | 1 |
Echinococcus granulosus | cyclins | 0.0185 | 0.3185 | 0.6388 |
Echinococcus granulosus | cyclins | 0.0185 | 0.3185 | 0.6388 |
Trypanosoma cruzi | cAMP-dependent protein kinase catalytic subunit 3 | 0.0212 | 0.4985 | 1 |
Echinococcus granulosus | cyclin B3 1 | 0.0185 | 0.3185 | 0.6388 |
Toxoplasma gondii | AGC kinase | 0.0212 | 0.4985 | 1 |
Loa Loa (eye worm) | AGC/PKA protein kinase | 0.0212 | 0.4985 | 0.4985 |
Echinococcus granulosus | cyclins | 0.0185 | 0.3185 | 0.6388 |
Trichomonas vaginalis | cyclins, putative | 0.0185 | 0.3185 | 0.6388 |
Trypanosoma brucei | mitotic cyclin 6 | 0.0185 | 0.3185 | 0.6388 |
Toxoplasma gondii | hypothetical protein | 0.014 | 0.0265 | 0.0532 |
Schistosoma mansoni | cyclin B | 0.0185 | 0.3185 | 0.6388 |
Trypanosoma brucei | protein kinase A catalytic subunit, putative | 0.0212 | 0.4985 | 1 |
Echinococcus granulosus | cyclins | 0.0185 | 0.3185 | 0.6388 |
Echinococcus multilocularis | cAMP dependent protein kinase catalytic subunit | 0.0212 | 0.4985 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0185 | 0.3185 | 0.3185 |
Entamoeba histolytica | cyclin, putative | 0.0185 | 0.3185 | 0.6388 |
Echinococcus granulosus | cyclin B | 0.0185 | 0.3185 | 0.6388 |
Echinococcus multilocularis | cyclins | 0.0185 | 0.3185 | 0.6388 |
Entamoeba histolytica | cyclin family protein | 0.0185 | 0.3185 | 0.6388 |
Echinococcus multilocularis | cAMP dependent protein kinase catalytic subunit | 0.0212 | 0.4985 | 1 |
Echinococcus granulosus | cAMP dependent protein kinase catalytic subunit | 0.0212 | 0.4985 | 1 |
Entamoeba histolytica | cyclin, putative | 0.0185 | 0.3185 | 0.6388 |
Echinococcus multilocularis | cyclin B3 1 | 0.0185 | 0.3185 | 0.6388 |
Giardia lamblia | G2/mitotic-specific cyclin B | 0.0185 | 0.3185 | 0.6388 |
Trichomonas vaginalis | cyclin D, putative | 0.0185 | 0.3185 | 0.6388 |
Trypanosoma cruzi | cAMP-dependent protein kinase catalytic subunit 1 | 0.0212 | 0.4985 | 1 |
Echinococcus granulosus | cyclin b3 | 0.0185 | 0.3185 | 0.6388 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0185 | 0.3185 | 0.6388 |
Leishmania major | CYC2-like cyclin, putative,cyclin 6, putative | 0.0185 | 0.3185 | 0.6388 |
Trypanosoma cruzi | cAMP-dependent protein kinase catalytic subunit 2 | 0.0212 | 0.4985 | 1 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0212 | 0.4985 | 1 |
Echinococcus multilocularis | cyclin b3 | 0.0185 | 0.3185 | 0.6388 |
Trichomonas vaginalis | cyclins, putative | 0.0185 | 0.3185 | 0.6388 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0212 | 0.4985 | 1 |
Giardia lamblia | Hypothetical protein | 0.0185 | 0.3185 | 0.6388 |
Trichomonas vaginalis | cyclin B, putative | 0.0185 | 0.3185 | 0.6388 |
Trichomonas vaginalis | cyclin B3, putative | 0.0185 | 0.3185 | 0.6388 |
Leishmania major | protein kinase A catalytic subunit | 0.0212 | 0.4985 | 1 |
Echinococcus granulosus | cyclins | 0.0185 | 0.3185 | 0.6388 |
Giardia lamblia | Kinase, AGC PKA | 0.0212 | 0.4985 | 1 |
Echinococcus multilocularis | cyclins | 0.0185 | 0.3185 | 0.6388 |
Giardia lamblia | Cyclin A | 0.0185 | 0.3185 | 0.6388 |
Echinococcus multilocularis | cyclins | 0.0185 | 0.3185 | 0.6388 |
Entamoeba histolytica | PH domain containing protein kinase, putative | 0.0212 | 0.4985 | 1 |
Trypanosoma cruzi | cyclin, putative | 0.0185 | 0.3185 | 0.6388 |
Echinococcus granulosus | enhancer of mRNA decapping protein 4 | 0.0207 | 0.4643 | 0.9314 |
Echinococcus multilocularis | cyclins | 0.0185 | 0.3185 | 0.6388 |
Echinococcus granulosus | cAMP dependent protein kinase catalytic subunit | 0.0212 | 0.4985 | 1 |
Entamoeba histolytica | PH domain containing protein kinase, putative | 0.0212 | 0.4985 | 1 |
Brugia malayi | Cyclin, N-terminal domain containing protein | 0.0185 | 0.3185 | 0.3185 |
Echinococcus multilocularis | cyclin B | 0.0185 | 0.3185 | 0.6388 |
Leishmania major | cyclin | 0.0185 | 0.3185 | 0.6388 |
Trypanosoma cruzi | cyclin, putative | 0.0185 | 0.3185 | 0.6388 |
Loa Loa (eye worm) | cyclin domain-containing protein | 0.0289 | 1 | 1 |
Trypanosoma cruzi | cyclin 6, putative | 0.0185 | 0.3185 | 0.6388 |
Trichomonas vaginalis | cyclin D, putative | 0.0185 | 0.3185 | 0.6388 |
Plasmodium vivax | cAMP-dependent protein kinase catalytic subunit, putative | 0.0212 | 0.4985 | 1 |
Trypanosoma cruzi | CYC2-like cyclin, putative | 0.0185 | 0.3185 | 0.6388 |
Echinococcus multilocularis | G2:mitotic specific cyclin B3 | 0.0185 | 0.3185 | 0.6388 |
Loa Loa (eye worm) | hypothetical protein | 0.0185 | 0.3185 | 0.3185 |
Toxoplasma gondii | AGC kinase | 0.0212 | 0.4985 | 1 |
Echinococcus granulosus | cAMP dependent protein kinase catalytic subunit | 0.0212 | 0.4985 | 1 |
Trichomonas vaginalis | cyclin B, putative | 0.0185 | 0.3185 | 0.6388 |
Leishmania major | protein kinase A catalytic subunit isoform 2 | 0.0212 | 0.4985 | 1 |
Brugia malayi | cAMP-dependent protein kinase catalytic subunit, putative | 0.0212 | 0.4985 | 0.4985 |
Trichomonas vaginalis | cyclin A, putative | 0.0185 | 0.3185 | 0.6388 |
Entamoeba histolytica | cyclin family protein | 0.0185 | 0.3185 | 0.6388 |
Trichomonas vaginalis | cyclins, putative | 0.0185 | 0.3185 | 0.6388 |
Onchocerca volvulus | 0.0185 | 0.3185 | 0.5 | |
Trypanosoma cruzi | cAMP-dependent protein kinase catalytic subunit 3 | 0.0212 | 0.4985 | 1 |
Trichomonas vaginalis | cyclins, putative | 0.0185 | 0.3185 | 0.6388 |
Loa Loa (eye worm) | AGC/PKA protein kinase | 0.0212 | 0.4985 | 0.4985 |
Loa Loa (eye worm) | hypothetical protein | 0.0212 | 0.4985 | 0.4985 |
Echinococcus multilocularis | cyclins | 0.0185 | 0.3185 | 0.6388 |
Trichomonas vaginalis | cyclin B, putative | 0.0185 | 0.3185 | 0.6388 |
Echinococcus multilocularis | cyclins | 0.0185 | 0.3185 | 0.6388 |
Echinococcus multilocularis | cAMP dependent protein kinase catalytic subunit | 0.0212 | 0.4985 | 1 |
Trypanosoma brucei | cAMP-dependent protein kinase catalytic subunit 1 | 0.0212 | 0.4985 | 1 |
Schistosoma mansoni | cyclins | 0.0185 | 0.3185 | 0.6388 |
Leishmania major | protein kinase A catalytic subunit isoform 1 | 0.0212 | 0.4985 | 1 |
Trichomonas vaginalis | cyclin B, putative | 0.0185 | 0.3185 | 0.6388 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
D150 (functional) | = 1.3 mg kg-1 | Dose required to decrease heart rate after iv injection to spinal rats | ChEMBL. | 7452671 |
logD (ADMET) | = 0.32 | Partition coefficient (logD7.4) | ChEMBL. | 7452671 |
pKa | = 10.9 | Dissociation constant (pKa) | ChEMBL. | 7452671 |
Relative activity (functional) | = 0.48 | Evaluated for decreased heart rate in spinal rats, relative activity was determined | ChEMBL. | 7452671 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.